KRON

Kronos Bio (KRON)

Kronos Bio Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KRON

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	05:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/05/10	05:08	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRON	Kronos Bio Inc
2024/05/10	05:05	GlobeNewswire Inc.	Kronos Bio Reports First-Quarter 2024 Financial Results	NASDAQ:KRON	Kronos Bio Inc
2024/04/25	05:01	GlobeNewswire Inc.	Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:KRON	Kronos Bio Inc
2024/03/21	20:05	GlobeNewswire Inc.	Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results	NASDAQ:KRON	Kronos Bio Inc
2024/03/08	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/03/08	06:05	GlobeNewswire Inc.	Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway	NASDAQ:KRON	Kronos Bio Inc
2024/03/06	06:44	GlobeNewswire Inc.	Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting	NASDAQ:KRON	Kronos Bio Inc
2024/03/05	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/02/28	06:05	GlobeNewswire Inc.	Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/02/24	10:03	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/01/25	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2024/01/06	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/01/06	08:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2024/01/06	08:26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2023/12/19	06:06	GlobeNewswire Inc.	Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate	NASDAQ:KRON	Kronos Bio Inc
2023/12/14	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2023/12/14	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRON	Kronos Bio Inc
2023/12/04	22:00	GlobeNewswire Inc.	Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	NASDAQ:KRON	Kronos Bio Inc
2023/11/28	06:05	GlobeNewswire Inc.	Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference	NASDAQ:KRON	Kronos Bio Inc
2023/11/14	06:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2023/11/14	06:05	GlobeNewswire Inc.	Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results	NASDAQ:KRON	Kronos Bio Inc
2023/11/14	06:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRON	Kronos Bio Inc
2023/11/03	05:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRON	Kronos Bio Inc
2023/11/03	05:05	GlobeNewswire Inc.	Kronos Bio Announces Plan to Optimize Resource Allocation, Restructure and Contain Costs Following Positive Preliminary Clinical Data from its KB-0742 Phase 1/2 Study	NASDAQ:KRON	Kronos Bio Inc
2023/11/03	01:00	GlobeNewswire Inc.	Kronos Bio Presents Positive Preliminary Data from the Phase 1 Dose Escalation Portion of the Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting	NASDAQ:KRON	Kronos Bio Inc
2023/10/27	21:00	GlobeNewswire Inc.	Kronos Bio To Present Positive Preliminary Data from Phase 1 Dose Escalation Portion of Ongoing Phase 1/2 KB-0742 Study at the Connective Tissue Oncology Society Annual Meeting	NASDAQ:KRON	Kronos Bio Inc